Live Breaking News & Updates on Nephrectomy

Stay informed with the latest breaking news from Nephrectomy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nephrectomy and stay connected to the pulse of your community

Westminster Mom Has So Much Heart, She Donated a Kidney to Her Toddler

When their son, Hank, was born with end stage kidney failure, Jessica and Steven Shockney of Westminster knew what they had to do.After watching him suffer on

Steven-shockney , National-donor-day , Health-medical-pharma , Jessica , Bluey , Valentine , Hanks , Hank , Nephrectomy , Organ-transplantation , Draft-matt-schneider , Organ-donation

Laparoscopic Donor Nephrectomy Has Better Outcomes Than Open Donor Nephrectomy

According to a new study, laparoscopic donor nephrectomy performed better than open donor nephrectomy regarding hospital stay length, urinary catheterization, operating time, and blood loss.

Turkey , Researchgate-ahmet-keles , Llyode-ratner , Ahmet-keles , Istanbul-medeniyet-university-in-uskudar , Istanbul-medeniyet-university , Laparoscopic-donor-nephrectomy- , Open-donor-nephrectomy , Laparoscopic-donor-nephrectomy , Open-door-nephrectomy , Laparoscopic , Open-door

Donor, recipient celebrate 25 years since region's first laparoscopic kidney transplant

A local brother and sister made history Friday, as part of what led to a change in how kidney

Cincinnati , Ohio , United-states , Jill-reffner , Steve-woodle , David-wilmer , Uc-health , Health-medical-pharma , Organ-donation , Kidney-transplantation , Laparoscopy , Organ-transplantation

Adjuvant Pembrolizumab Improves OS in Select Patients With RCC After Nephrectomy

Adjuvant treatment with pembrolizumab significantly improved overall survival vs placebo in patients with renal cell carcinoma at intermediate-high or high risk of recurrence after nephrectomy, or after nephrectomy and resection of metastatic lesions, meeting a key secondary end point of the phase 3 KEYNOTE-564 trial.

Merck-research-laboratories , Cancers-symposium , Pembrolizumab , Adjuvant-pembrolizumab , Rcc , Renal-cell-carcinoma , Genitourinary-cancer , Nephrectomy , Keynote-564-trial , Keytruda , Merck

Clinical Challenges: Role of Surgery in Metastatic RCC

Research needed to examine role of nephrectomy in the era of modern immunotherapy combos

New-york , United-states , Delaware , Fox-chase-cancer-center , Pennsylvania , Philadelphia , Leah-lawrence , Andresf-correa , William-huang , International-metastatic , Langone-health , Database-consortium